Acute suicidal behavior following ayahuasca ingestion in a clinical trial setting: a case report.
Braz J Psychiatry September 29, 2025 José Augusto S. Reis, Giordano N. Rossi, Anna Beatriz V. Zacharias et al.
A case report describes an instance of acute suicidal behavior that occurred after a participant ingested ayahuasca in a clinical trial setting. The report details the circumstances and clinical presentation of this adverse event, highlighting a potential risk associated with ayahuasca use even within a controlled research environment. The authors suggest that such reactions, though rare, warrant careful screening and monitoring of participants in psychedelic research.